BOSTON, MA — (Marketwired) — 06/06/13 — , the medtech industry-s leading provider of strategic partnership and investment conferences, announced today that it will host the investor conference on , at the . There are many emerging companies that are presenting at an IN3 event for the first time, including .
(Berkeley, Calif.), with its origins at the Karolinska Institute in Stockholm, has developed and will soon launch clinical trials for an innovative medical device that captures and removes an extremely broad range of bacteria, viruses, parasites and disease-causing agents from circulating human blood — directly, quickly and simultaneously. At the same time it removes pathogens, ExThera-s is also engineered to reduce circulating levels of bacterial toxins and pro-inflammatory cytokines that play an important role in the progression of bloodstream infection to a full systemic inflammatory response. “We know of no other therapy capable of sweeping all of these agents from the blood of bacteremic and viremic patients in a brief course of treatment,” said , CEO, ExThera Medical. “We are very much looking forward to showcasing our technology at In3 Boston because of the sophisticated investors that are drawn to IN3 events.”
The Investment in Innovation conference will feature presentations by more than 35 early-, mid- and late-stage start-up companies that are seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. The conference also will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought leaders discussing the most pressing issues facing the global device industry in 2013 and beyond. Panel topics will include: ; ; and, In addition, large company/VC meet-and-greets will be held to facilitate interaction between these two influential groups and conference participants. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.
These interviews will be featured post-conference at , to which a link will be provided to participating companies for their unrestricted use; availability of these video interviews will be broadly promulgated within the medtech industry. All one-on-one interviews with presenting-company CEOs will take place at, and during the IN3 Boston conference and be organized by , President of To schedule the free on-camera interviews contact , or call +1-508-359-4005, x108.
This special event will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in Boston should contact at 949-797-7142, or email .
IN3 Medical Device 360 degrees Boston will be held at the . Event co-sponsors to date include , , , , , and . Visit for more information.
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI () has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108